Virax Biolabs closes $3.3 million preferred option exercise, issuing up to 548,000 ordinary shares
LONDON, July 10. A $3.3 million exercise of preferred investment options closed at Virax Biolabs Group Limited on Thursday, the company said. The close covered the purchase of up to 548,000 ordinary shares. The London-based company, which trades on Nasdaq under the ticker VRAX, had previously announced the deal.
Key takeaways
- Virax Biolabs Group Limited closed a $3.3 million exercise of preferred investment options on Thursday, July 10, 2026.
- The exercise covered the purchase of up to 548,000 ordinary shares tied to the company's preferred investment options.
- The $3.3 million figure represents gross proceeds, with no fees or expenses specified in the release.
- Virax Biolabs is a London-based company listed on the Nasdaq Capital Market under the ticker symbol VRAX.
- The company had previously announced the deal before its closing was confirmed.
LONDON, July 10. A $3.3 million exercise of preferred investment options closed at Virax Biolabs Group Limited on Thursday, the company said. The close covered the purchase of up to 548,000 ordinary shares. The London-based company, which trades on Nasdaq under the ticker VRAX, had previously announced the deal.
Transaction details
The instruments exercised were preferred investment options tied to ordinary shares of Virax Biolabs Group Limited, according to the company's release. The $3.3 million represents gross proceeds. The release did not specify fees or expenses to be deducted from that figure.
The ordinary shares carry a par value, the filing states, though the specific amount was not included in the release summary.
About Virax Biolabs Group Limited
Virax Biolabs Group Limited is listed on the Nasdaq Capital Market under the ticker symbol VRAX and is headquartered in London. The closing was confirmed in a release dated July 10, 2026.
Note: The source summary was truncated and provided limited disclosures. This article reflects only the facts contained in the available text.